Corrigendum to “Asundexian in atrial fibrillation – Can pharmacodynamic data explain the failure?” [Thromb. Res. 236 (2024) 236–239 TR_8963]
Corrigendum to “Asundexian in atrial fibrillation – Can pharmacodynamic data…
Ler MaisCorrigendum to “Asundexian in atrial fibrillation – Can pharmacodynamic data…
Ler MaisProthrombotic plasma fibrin clot phenotype is associated with spontaneous echo…
Ler MaisLiver health in hemophilia in the era of gene therapy…
Ler MaisThrombotic risk and features of patients with inferior vena cava…
Ler MaisFerumoxytol-enhanced MRI assessment of venous Thrombus resolution and macrophage content…
Ler MaisBleeding phenotype according to factor level in 825 children with…
Ler MaisRisk assessment tools for bleeding in patients with unprovoked venous…
Ler MaisRapid high-throughput method for investigating physiological regulation of neutrophil extracellular…
Ler MaisOral anticoagulation in patients with left ventricular thrombus – a…
Ler MaisAltered fibrin clot phenotype in young adults with intracerebral hemorrhage…
Ler Mais